| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 9th, 2004 | 23 | Yes |
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-
N-((4-isopropylcyclohexyl)carbonyl)phenylalanine
N-[[TRANS-4-(1-METHYLETHYL)CYCLOHEXYL]CARBONYL]-D-PHENYLALANINE
n-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine
N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 2.56 | 10.3 | -55.73 | 1 | 4 | -1 | 69 | 316.421 | 6 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Therapy | antidiabetic | SMDC Pharmakon |
| PUBCHEM_PATENT_ID | EP0196222A2; EP0196222B1; EP0526171A2; EP0526171B1; EP0924209A1; EP0965339A1; EP1011673A1; US4816484; US5463116; US5488150; US6143323; USRE34878; WO1998022105A1; WO1998056378A1; WO1999032112A1; WO2000061127A2; WO2000078724A2; WO2000078726A1 | IBM Patent Data |
| PUBCHEM_PATENT_ID | US4501002; WO1999061004A1 | IBM Patent Data |
